Clinical Trials Browser

Phase 2 × Completed × TIC10 compound × Clear all

NCT03034200 2024-11-26

Phase 2 Study of ONC201 in Neuroendocrine Tumors

Phase 2 Completed

30 enrolled 12 charts

Neuroendocrine Tumors

NCT03394027 2022-08-23

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

Phase 2 Completed

30 enrolled 15 charts

BreastGynecologic

Neoplasm Metastasis, Endometrial Neoplasms, Breast Neoplasms, Male, Triple Negative Breast Neoplasms